Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Jan '16 Jan 2, 2016	Jan '15 Jan 3, 2015	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
United States Revenue	18.17B	17.13B	16.32B
Germany Revenue	-	2.76B	2.54B
China Revenue	-	1.91B	2.11B
India Revenue	-	1.87B	1.82B
Switzerland Revenue	-	1.87B	1.75B
Japan Revenue	-	1.48B	1.44B
Netherlands Revenue	-	-	1.12B
United Kingdom Revenue	-	1.34B	1.19B
All Other Countries Revenue	-	15.98B	14.79B
Total International Revenue	28.41B	27.20B	25.63B
Revenue (Other)	-	-1.34B	-1.19B
Revenue (Total)	46.59B	44.33B	41.95B

Revenue

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Jan '16 Jan 2, 2016	Jan '15 Jan 3, 2015	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
Established Pharmaceutical Products Revenue	5.82B	5.54B	5.19B
Nutritionals Revenue	8.25B	8.45B	8.41B
Diagnostics Revenue	9.98B	8.94B	9.34B
Medical Devices Revenue	22.52B	21.39B	18.99B
Other Segment Revenue	16.00M	17.00M	16.00M
Revenue (Total)	46.59B	44.33B	41.95B

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Jan '16 Jan 2, 2016	Jan '15 Jan 3, 2015	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
Established Pharmaceutical Products Operating Earnings	1.39B	1.29B	1.23B
Nutritionals Operating Earnings	1.43B	1.56B	1.51B
Diagnostics Operating Earnings	1.84B	1.74B	2.07B
Medical Devices Operating Earnings	7.67B	7.21B	6.15B
Operating Income (Other)	-4.98B	-3.75B	-4.14B
Operating Income (Total)	7.35B	8.05B	6.83B

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Jan '16 Jan 2, 2016	Jan '15 Jan 3, 2015	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
Organic Sales Growth	5.50%	9.60%